PRESS RELEASE : Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof -…

DGAP-News: Aladdin Healthcare Technologies SE / Key word(s): Letter of Intent/Alliance Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof 2021-01-22 / 09:10 The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof BERLIN/LONDON January 22, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, has signed a Memorandum of Understanding (MOU) with Consentia Ltd, with the goal of building a Blockchain platform based on Zero Knowledge Proof (ZKP) for safely sharing genomics and multi-omics data. Since genomic data analysis is growing in prominence for precision diagnosis and medicine, the need for fast and secure sharing of such data is increasing worldwide and requires appropriate tools to ensure people's data privacy. Aladdin will build a ZKP-based blockchain platform to gather global healthcare data with Consentia, an innovative blockchain development start-up in the UK and Hongkong, led by Paul Sitoh, one of the most sought-after experts in blockchain technology and co-builder of Hyperledger Fabric. Nowadays, the healthcare industry is dominated by a lot of time-consuming due diligence based on privacy issues. Zero Knowledge Proof (ZKP) is a cryptography method by which data can be proven without actually showing or sharing any additional information. Both, Aladdin and Consentia will collaborate to build a proprietary data-tool based on ZKP for eradicating passwords and protecting the identities of global patients that submit multi-omics and genetic healthcare data to centralized databases. Furthermore, the parties will develop a new blockchain platform based on the ZKP-tool where users and healthcare professionals will be able to safely access and store the healthcare data. Wade Menpes-Smith comments: "Aladdin has taken a massive step in the field of Blockchain applications for Healthcare by signing this Agreement. We are more than happy to have Consentia at our side as valuable partner in this important challenge. We want to protect people's identities while giving our innovative contribution to medical research. This is a big chance for expanding our business opportunities by commercializing the platform in the future with existing and new partners at a global level." About Aladdin Healthcare Technologies SE Aladdin Healthcare Technologies SE (and its wholly owned subsidiary Aladdin Healthcare Technologies Ltd.) is a leading developer of AI healthcare diagnostics and drug discovery applications that can accelerate both early stage disease diagnosis and the end-to-end drug discovery process. Aladdin targets age-related diseases including a significant focus on Alzheimer's disease. Aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to confidentially and securely gather targeted data including genome, tabular, MRI, PET, cognition and other lifestyle data. These datasets are then analysed by our award-winning AI team and used to develop proprietary AI tools that can assist healthcare professionals to more accurately and efficiently diagnose age-related diseases. This new diagnostic process will save significant time and costs for healthcare professionals. Additionally, our AI drug discovery platform will be used by pharmaceutical Companies to speed up drug development, clinical trials and predict outcomes more accurately. Website Link: http://www.aladdinid.com GSIN: A12ULL ISIN: DE000A12ULL2 TICKER SYMBOL: NMI For further information: Aladdin Healthcare Technologies Ltd. 24-26 Baltic Street West London EC1Y 0UR Phone +44 7714 719696 Email: info@aladdinid.com Contact Press CROSS ALLIANCE communication GmbH Sara Pinto Phone +49 89 1250 90330 Email: pi@crossalliance.de http://www.crossalliance.de =---------------------------------------------------------------------------------------------------------------------- 2021-01-22 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at http://www.dgap.de =---------------------------------------------------------------------------------------------------------------------- Language: English Company: Aladdin Healthcare Technologies SE Unter den Linden 10 10117 Berlin Germany Phone: 030 700140449 E-mail: info@aladdinid.com Internet: http://www.aladdinid.com ISIN: DE000A12ULL2 WKN: A12ULL Listed: Regulated Market in Dusseldorf EQS News ID: 1162478 End of News DGAP News Service =----------

(MORE TO FOLLOW) Dow Jones Newswires

January 22, 2021 03:11 ET (08:11 GMT)

See more here:
PRESS RELEASE : Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof -...

Related Posts
This entry was posted in $1$s. Bookmark the permalink.